Johnson & Johnson's financial health status assessment: based on the comprehensive financial statement analysis
DOI:
https://doi.org/10.62051/j2hnc996Keywords:
DuPont analysis; balance sheet; income statement; cash flow statementAbstract
With the development of society and the improvement of people's living standards, a healthy life has been paid more and more attention. However, some insurmountable viruses are like obstacles to the road, threatening people's health. How to deal with these viruses and how to ensure human health and safety have become an urgent problem to be solved. Founded in 1886, Johnson & Johnson Company, as a well-known enterprise with a history of one hundred years, firmly believes that its core values come from the corporate creed. Over the years, Johnson & Johnson has always been committed to social feedback and taking practical actions to practice corporate value. Johnson & Johnson topped the 2020 list of the world's most valuable pharmaceutical companies. The success of Johnson & Johnson is closely related to its continuous innovation and pioneering spirit. The company's continuous innovation in medical devices, drugs, consumer health products and other fields makes Johnson & Johnson always maintain the leading position in the industry. This paper first discusses the development process and business strategy of Johnson & Johnson, and then systematically evaluates the business performance of Johnson & Johnson from both theoretical and empirical aspects. Based on the principle of selection indicators such as rationality and comparability,In order to study the financial statements of Johnson & Johnson, this paper selects a variety of indicators such as sales gross profit margin, net interest rate of total assets, inventory turnover, current assets turnover and total assets turnover for analysis, and uses DuPont analysis method. As a result of the analysis, in the past two years, the performance of Johnson & Johnson has been mediocre, and it is necessary to adjust the management to improve the asset management efficiency and operating capacity, so as to increase the profit margin to enhance the development capacity.
Downloads
References
[1] Chen Fang.performance management [M]. Shenzhen: Haitian Publishing House, 2002.
[2] Liu Yi. Analysis of the marketing strategy of Johnson & Johnson Corporation in China [D]. Changchun: Jilin University, 2019.
[3] Tang Jingyang."Pharmaceutical king" competition for multinational pharmaceutical companies who is the strongest [N]. International Finance News, 2024-02-26 (011).
[4] Zhang Xi. The legendary creatures of innovative pharmaceutical companies show the report card of "going overseas" [N]. Nanjing Daily, 2023-07-26 (A04).
[5] He Xianmin. Form and strategy of localization of multinational companies in China [J]. Hebei Academic Journal, 2010,30 (02): 154-157.
[6] Zhang He, Wang Zhenya, Kong Tianjiao, Zhao Yuanji, Hou Jiaxin. Johnson & Johnson containing talcum baby powder will be suspended worldwide [N]. Health Times, 2022-08-16 (003).
Downloads
Published
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.








